Last Updated: 07/24/2014 21:03:53
CRXIF Stock Chart - 1 Month
CRXIF Stock Chart - 3 Month
CRXIF Stock Chart - 6 Month
CRXIF Stock Chart - 1 Year
CRXIF Stock Chart - 2 Year
A $81.3 Billion Offering Invites Fast Money Anthropic arrived in public markets with the sort of numbers that make traders reach for both a calculator and a helmet. The company priced 980 million Class A shares at $83 on November 18, 2026, raising roughly $81.3 billion, then opened at $111.50 when it began Nasdaq trading on November 19. That is a monster debut by any...
Continue Reading
A cancer-market announcement ought to make investors pause before they reach for a spreadsheet. Specialised Therapeutics and DKSH have signed an exclusive partnership to bring oncology therapies into Vietnam, and the human case is painfully clear: the country recorded an estimated 180,000 new cancer cases and more than 120,000 deaths annually in the 2022 GLOBOCAN data....
Continue Reading
Something is badly out of sequence in the Build-A-Bear shareholder alert, and that matters before anybody gets carried away by the legal boilerplate. The notice says investors who bought NYSE: BBW securities from March 28, 2026 through August 26, 2026 may be covered by a proposed federal securities class action. It also says the lead-plaintiff deadline is January 19,...
Continue Reading
A travel ranking is a map, not a balance sheet, and that distinction matters more than the glossy numbering. TTW has put Australia at the head of its editorial list of the 50 best countries to visit in 2027, followed by Switzerland, Japan, Canada and Thailand. Fair enough. Those are formidable tourism brands with the scenery, infrastructure and cultural pull to back up...
Continue Reading
Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...
Continue Reading
Three hundred-plus pipelines is a lot of messy plumbing to tame, and NatGasHub has apparently found a lucrative way to do it. The Houston software company landed at No. 182 on Deloitte’s 2026 Technology Fast 500 after reporting 391% revenue growth from 2022 through 2025. That is a serious number, even in a ranking built to showcase companies sprinting uphill. More...
Continue Reading
A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...
Continue Reading
A failing tricuspid valve is not a spreadsheet problem, and that matters before anybody gets carried away with a glossy conference presentation. Venus Medtech's Cardiovalve unit has reported results from TARGET in a population that was old, sick and largely out of good surgical options. That is precisely where a less invasive replacement therapy has to prove it can do...
Continue Reading
Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....
Continue Reading
Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...
Continue Reading
Colossus SSP Teams Up with Scope3 for Green Media Solutions Colossus Media LLC, also known as Colossus SSP, is making strides in the advertising sector by integrating with Scope3, a prominent provider of carbon emissions data. This collaboration empowers Colossus SSP to present superior green media solutions, thereby allowing brands and agencies to show greater commitment...
Continue Reading
SSC Security Services Corp. Completes Subsidiary Amalgamation SSC Security Services Corp., commonly referred to as SSC, is pleased to announce the successful completion of a horizontal short-form amalgamation of its wholly owned operating subsidiaries, Logixx Security Inc. and SRG Security Resource Group Inc. This strategic move is part of a larger effort to streamline...
Continue Reading
Biden Administration Takes a Firm Stand on Airline Competition The U.S. government is stepping up efforts to ensure fair competition in the airline industry. The Justice Department's Antitrust Division, along with the Transportation Department, has initiated a comprehensive public inquiry into the landscape of air travel competition. Prioritizing Airline Competition...
Continue Reading
Atlassian's Strong Fiscal Performance Atlassian Corp Plc (NASDAQ: TEAM) has recently delivered its fiscal first quarter results, much to the delight of analysts and investors alike. The report highlighted impressive growth in both its cloud and data center sectors, which significantly contributed to its revenues, surpassing Wall Street's expectations. Highlights from the...
Continue Reading
Actinium Pharmaceuticals Class Action Lawsuit Overview In recent developments surrounding Actinium Pharmaceuticals, Inc. (NYSE American: ATNM), investors are presented with an opportunity to lead a securities fraud class action lawsuit. This initiative is spearheaded by Rosen Law Firm, a reputable global entity vigorously advocating for investor rights. Key Details for...
Continue Reading